Is the Generally Held View That Intravenous Dihydroergotamine Is Effective in Migraine Based on Wrong "General Consensus" of One Trial? A Critical Review of the Trial and Subsequent Quotations.

Abstract

BACKGROUND:

The claim that parenteral dihydroergotamine (DHE) is effective in migraine is based on one randomized, placebo-controlled, crossover trial from 1986. The aim of this review was to critically evaluate the original article. It was also found to be of interest to review quotes concerning the results in the more than 100 articles subsequently referring to the article.

METHODS:

The correctness of the stated effect of intravenous DHE in the randomized clinical trial (RCT) was first critically evaluated. Then, Google Scholar was searched for references to the article and these references were classified as to whether they judged the reported RCT as positive or negative.

RESULTS:

The design of the RCT, with a crossover within one migraine attack, only allows evaluation of the results for the first period and the effect of DHE and placebo were quite comparable. About 151 references were found for the article in Google scholar. Among the 95 articles with a judgment on the efficacy of intravenous DHE in the RCT, 90 stated that DHE was effective or likely effective whereas only 5 articles stated that DHE was ineffective.

CONCLUSIONS:

Despite a "negative" RCT, authors of subsequent articles on the efficacy of parenteral DHE overwhelmingly reported this RCT as "positive." This is probably due to the fact that the authors concluded in the abstract that DHE is effective, and to a kind of "wrong general consensus."

• Authors: Goran Bekan, Peer Tfelt-Hansen
• Journal: Headache (Headache) Vol. 56 Issue 9 Pg. 1482-1491 (Oct 2016) ISSN: 1526-4610 [Electronic] United States
• PMID: 27595607 (Publication Type: Journal Article, Review)
• Copyright: © 2016 American Headache Society.

Chemical References

• Analgesics, Non-Narcotic
• Dihydroergotamine

Topics

• Administration, Intravenous
• Analgesics, Non-Narcotic (administration & dosage)
• Dihydroergotamine (administration & dosage)
• Humans
• Migraine Disorders (drug therapy)
• Randomized Controlled Trials as Topic (methods)
• Research Design